Nesiritide (Natrecor) is the recombinant form of the 32 amino acid human B-type
natriuretic peptide, which is normally produced by the ventricular myocardium.
Learn about Natrecor (Nesiritide) may treat, uses, dosage, side effects, drug
interactions, warnings, patient labeling, reviews, and related medications.
Nesiritide, a recombinant human B-type natriuretic peptide, is the first in a new
drug class for the treatment of decompensated heart failure. The drug binds to ...
Medscape - Indication-specific dosing for Natrecor (nesiritide), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
Jul 7, 2011 ... Nesiritide is approved in the United States for early relief of dyspnea in patients
with acute heart failure. Previous meta-analyses have raised ...
Feb 15, 2006 ... Nesiritide improves short-term hemodynamics in hospitalized patients with acute
decompensated heart failure who have not benefited from ...
Jun 13, 2016 ... Acute decompensated heart failure (HF) is a common and potentially fatal cause
of acute respiratory distress. The clinical syndrome is ...
Drug information on Natrecor (nesiritide), includes drug pictures, side effects,
drug interactions, directions for use, symptoms of overdose, and what to avoid.
Oct 21, 2007 ... Nesiritide is a medication used to treat acutely decompensated congestive heart
failure with dyspnea at rest or with minimal exertion (such as ...
We also assessed nesiritide use at the hospital level (the denominator being all
hospitalizations with HF in a given hospital). Hierarchical generalized linear ...